Zero Diffusive Sodium Balance in Hemodialysis Provided by an Algorithm-Based Electrolyte Balancing Controller: A Proof of Principle Clinical Study
- PMID: 30260035
- DOI: 10.1111/aor.13328
Zero Diffusive Sodium Balance in Hemodialysis Provided by an Algorithm-Based Electrolyte Balancing Controller: A Proof of Principle Clinical Study
Abstract
Restoring and controlling fluid volume homeostasis is still a challenge in contemporary end-stage kidney disease patients treated by intermittent hemodialysis (HD) or hemodiafiltration (HDF). This primary target is achieved by ultrafiltration (dry weight probing) and control of intradialytic sodium transfer (dialysate-plasma Na gradient). The latter task is mostly ignored in clinical practice by applying a dialysate sodium prescription uniform for all patients of the dialysis center but unaligned to individual plasma sodium levels. Depending on the patient's natremia, a positive gradient gives rise to intradialytic diffusive sodium load and postdialytic thirst. On the contrary, a negative gradient may cause unwanted diffusive sodium removal and intradialytic symptoms. To overcome these challenges, a new conductivity-based electrolyte balancing algorithm embedded in a hemodialysis machine with the aim to achieve "zero diffusive sodium balance" in HD and online HDF treatments was tested in the form of a prospective clinical trial. The study comprised two phases: a first phase with a conventional fixed-sodium dialysate (standard care phase), followed by a phase with the electrolyte balancing control (EBC) module activated (controlled care phase). The results show a reduction in the variability of the intradialytic plasma sodium concentration shift, but it is overlain by a small but statistically significant increase in the mean plasma sodium levels. However, no clinical manifestations were observed. This sodium load can be explained by the design of the algorithm based on dialysate conductivity instead of sodium concentration. Furthermore, the increase in plasma sodium can be corrected by taking into account the potassium shift during the treatment. This study showed that the EBC module incorporated in the HD machine is able to automatically individualize the dialysate sodium to the patient's plasma sodium without measuring or calculating predialytic plasma levels from previous laboratory tests. This tool has the potential to facilitate fluid management, to control diffusive sodium flux, and to improve intradialytic tolerance in daily clinical practice.
Keywords: Conductivity; Diffusive sodium balance; Electrolyte balance; Hemodialysis; Online hemodiafiltration; Renal replacement therapy; Sodium gradient.
© 2018 The Authors. Artificial Organs published by Wiley Periodicals, Inc. on behalf of International Center for Artificial Organ and Transplantation (ICAOT).
Similar articles
-
Automated individualization of dialysate sodium concentration reduces intradialytic plasma sodium changes in hemodialysis.Artif Organs. 2019 Oct;43(10):1002-1013. doi: 10.1111/aor.13463. Epub 2019 Apr 29. Artif Organs. 2019. PMID: 30939213 Free PMC article. Clinical Trial.
-
Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration.Artif Organs. 2021 Aug;45(8):E280-E292. doi: 10.1111/aor.13923. Epub 2021 Mar 8. Artif Organs. 2021. PMID: 33507535
-
Sodium flux during hemodialysis and hemodiafiltration treatment of acute kidney injury: Effects of dialysate and infusate sodium concentration at 140 and 145 mmol/L.Artif Organs. 2023 Jun;47(6):999-1006. doi: 10.1111/aor.14487. Epub 2023 Jan 9. Artif Organs. 2023. PMID: 36527419
-
Sodium balance in maintenance hemodialysis.Semin Dial. 2010 Nov-Dec;23(6):549-55. doi: 10.1111/j.1525-139X.2010.00794.x. Semin Dial. 2010. PMID: 21175831 Review.
-
Sodium balance in hemodialysis therapy.Semin Dial. 2003 Sep-Oct;16(5):351-5. doi: 10.1046/j.1525-139x.2003.16070.x. Semin Dial. 2003. PMID: 12969379 Review.
Cited by
-
The role of intra- and interdialytic sodium balance and restriction in dialysis therapies.Front Med (Lausanne). 2023 Dec 4;10:1268319. doi: 10.3389/fmed.2023.1268319. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38111694 Free PMC article. Review.
-
The difference between delivered and prescribed dialysate sodium in haemodialysis machines.Clin Kidney J. 2020 Mar 11;14(3):863-868. doi: 10.1093/ckj/sfaa022. eCollection 2021 Mar. Clin Kidney J. 2020. PMID: 33777369 Free PMC article.
-
Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities.J Bras Nefrol. 2019 Oct-Dec;41(4):550-559. doi: 10.1590/2175-8239-JBN-2019-0135. J Bras Nefrol. 2019. PMID: 31661543 Free PMC article.
-
The Janus-faced nature of complement in hemodialysis: interplay between complement, inflammation, and bioincompatibility unveiling a self-amplifying loop contributing to organ damage.Front Nephrol. 2024 Dec 3;4:1455321. doi: 10.3389/fneph.2024.1455321. eCollection 2024. Front Nephrol. 2024. PMID: 39691704 Free PMC article.
-
Multitargeted interventions to reduce dialysis-induced systemic stress.Clin Kidney J. 2021 Dec 27;14(Suppl 4):i72-i84. doi: 10.1093/ckj/sfab192. eCollection 2021 Dec. Clin Kidney J. 2021. PMID: 34987787 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical